|Articles|March 12, 2021
Nephron Pharmaceuticals Compounding Facility Integrates STERIS VHP® Biodecontamination System
Author(s)Steris Life Sciences
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
Regulatory Roundup—August 2026
2
Lilly's $2.875B Merida Deal Has Implications for Autoantibody Diseases
3
What to Know from the FDA’s End of August Activity
4
Pharma Fundamentals: Risks and Regulations for Hold Times in Biopharmaceuticals
5